Skip to main content

Military Health System

DOD P&T Committee: 2019 Meetings

Nov. 6-7, 2019

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: July 29, 2019
  • Pre-Proposal Teleconference: August 12, 2019 @ 11:00 a.m. Central 
  • Clinical/Cost Presentation Meeting Window: (no clinical presentations requested)
  • UF BPA & UF ADP Quotes Due: Sept. 20, 2019  
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • INSULINS - RAPID-ACTING AGENTS:
    • Admelog
    • Admelog Solostar
    • Afrezza
    • Apidra
    • Apidra Solostar
    • Fiasp
    • Humalog
    • Humalog Junior Kwikpen
    • Humalog Kwikpen U-100
    • Insulin Lispro
    • Insulin Lispro Kwikpen U-100
    • Novolog
    • Novolog Flexpen
  • PHOSPHODIESTERASE-5 INHIBITORS - ERECTILE DYSFUNCTION:
    • Cialis
    • Levitra
    • Staxyn
    • Stendra
    • Viagra
  • Annovera
  • Baqsimi
  • Drizalma Sprinkle
  • Duaklir Pressair
  • Gvoke
  • Inrebic
  • Katerzia
  • Nayzilam
  • Nourianz
  • Nubeqa
  • Rinvoq ER
  • Rozlytrek
  • Rybelsus
  • Temixys
  • Thiola EC
  • Tosymra
  • Turalio
  • Vyleesi
  • Wakix
  • Xenleta
  • Xpovio
  • Zelnorm
 

August 7-8, 2019

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: April 26, 2019
  • Pre-Proposal Teleconference: May 13, 2019 @ 1100 Central 
  • Clinical/Cost Presentation Meeting Window: (no clinical presentations requested)
  • UF BPA & UF ADP Quotes Due: June 21, 2019 
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • MULTIPLE SCLEROSIS AGENTS - INTERFERON:
    • Avonex
    • Betaseron
    • Extavia
    • Plegridy
    • Rebif
  • MULTIPLE SCLEROSIS AGENTS - METHYL FUMARATE:
    • Tecfidera
  • CORTICOSTEROIDS-IMMUNE MODULATORS - HIGH POTENCY:
    • Bryhali
    • Cordran Tape
    • Impoyz
    • Lexette
    • Ultravate
  • Adhansia XR
  • Balversa
  • Cutaquig
  • Dovato
  • Duobrii
  • Egaten
  • Emgality
  • Evekeo ODT
  • Ezallor
  • Jornay PM
  • Nucala
  • Piqray
  • Ruzurgi
  • Skyrizi
  • Slynd
  • Sunosi
  • Vyndaqel
 

May 8-9, 2019

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: Feb. 01, 2019
  • Pre-Proposal Teleconference: February 11, 2019 @ 11:00 a.m. Central 
  • Clinical/Cost Presentation Meeting Window: February - March 2019
  • UF BPA & UF ADP Quotes Due: March 29, 2019 
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • PROTON PUMP INHIBITORS - ALTERNATIVE DOSAGE FORMS:
    • Aciphex Sprinkle
    • Nexium Packet
    • Prevacid SoluTab
    • Protonix Packets
    • Zegerid Powder
  • PROTON PUMP INHIBITORS - CAPSULES AND TABLETS:
    • Dexilant
    • Zegerid
  • PULMONARY ARTERIAL HYPERTENSION - ENDOTHELIN RECEPTOR AGONIST:
    • Letairis
    • Opsumit
    • Tracleer
  • PULMONARY ARTERIAL HYPERTENSION - PROSTACYCLIN NEBULIZED THERAPY:
    • Tyvaso
    • Ventavis
  • PULMONARY ARTERIAL HYPERTENSION - PROSTACYCLIN ORAL THERAPY:
    • Orenitram ER
    • Uptravi
  • PULMONARY ARTERIAL HYPERTENSION - SOLUBLE GUANYLATE CYCLASE STIMULATOR:
    • Adempas
  • Apadaz
  • Bijuva
  • Diacomit

  • Inbrija

  • Lotemax SM

  • Mavenclad

  • Mayzent

  • Motegrity

  • Prograf

  • Qmiiz ODT

  • Rocklatan

  • Symjepi

  • Tirosint-SOL

 

Feb. 6-7, 2019

Uniform Formulary Request for Quote Information

  • UF BPA & UF ADP RFQ Documents Posted: Nov. 01, 2018
  • Pre-Proposal Teleconference: November 06, 2018 @ 11:00 a.m. Central 
  • Clinical/Cost Presentation Meeting Window: November - December 2018
  • UF BPA & UF ADP Quotes Due: Dec. 21, 2018 
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • INSULINS - RAPID ACTING AGENTS: -- Solicitation Cancelled
    • Admelog
    • Admelog Solostar
    • Afrezza
    • Apidra
    • Apidra Solostar
    • Fiasp
    • Humalog
    • Humalog Junior Kwikpen
    • Humalog Kwikpen U-100
    • Humalog Kwikpen U-200
    • Novolog
    • Novolog Flexpen
  • MIGRAINE AGENTS - CGRP PREVENTATIVE:
    • Aimovig
    • Ajovy
    • Emgality
  • ONCOLOGICAL AGENTS - 2ND-GEN ANTIANDROGENS:
    • Erleada
    • Xtandi
  • ONCOLOGICAL AGENTS - CYP-17 INHIBITORS:
    • Yonsa
    • Zytiga
  • Abilify Mycite
  • Aemcolo
  • Arakoda

  • Bryhali

  • Cequa

  • Daurismo

  • Firdapse

  • Granix vials

  • Inveltys

  • Krintafel

  • Lexette

  • Lorbrena

  • Nocdurna

  • Nuzyra

  • Oxervate

  • Revcovi

  • Ryclora

  • Seysara

  • Sympazan

  • Talzenna

  • Tegsedi

  • Tiglutik

  • Tolsura

  • Udenyca

  • Vitrakvi

  • Xelpros

  • Xofluza

  • Xospata

  • Xyosted

  • Yupelri

 
Last Updated: June 30, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery